本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Adaptive Biotechnologies Corp

13.18
-0.2100-1.57%
成交量:22.67萬
成交額:297.90萬
市值:20.27億
市盈率:-33.61
高:13.23
開:13.23
低:13.02
收:13.39
52周最高:20.76
52周最低:6.68
股本:1.54億
流通股本:1.17億
量比:0.49
換手率:0.19%
股息:- -
股息率:- -
每股收益(TTM):-0.3922
每股收益(LYR):-0.3922
淨資產收益率:-27.82%
總資產收益率:-6.79%
市淨率:9.26
市盈率(LYR):-33.61

資料載入中...

2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/06

重要事件披露

Form 8-K - Current report
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities